RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0044-1778700
The Ability to Detect the COVID-19 Genome Using Saliva Swabs in Comparison with Nasopharyngeal Swabs in Baghdad
Funding None.
Abstract
Objective Nasopharyngeal swab (NPS) sampling has been recommended by the World Health Organization (WHO) since the start of the COVID-19 pandemic, and real-time reverse transcription polymerase chain reaction (RT–PCR) is used to detect SARS-CoV- 2, the causative agent of COVID-19. This sampling technique is invasive and causes discomfort to the patient. Saliva swabs (SSs) can be used as an alternative noninvasive method; however, there are limited data confirming its suitability for the diagnosis of COVID-19. The aim of this study was to test the ability to detect COVID-19 using SSs in comparison with NPSs in the Baghdad Alkark sector.
Materials and Methods Six hundred and fifty patients were included in this study, and written informed consent was obtained from all the study participants. Paired NPSs and SSs were collected at the same time from each participant between days 3 and 5 after disease initiation. SSs were taken from the sublingual area. An RT‒PCR assay was used to detect the viral ribonucleic acid (RNA) of SARS-CoV-2 for the diagnosis of COVID-19. The chi-squared test was used for data analysis, with p < 0.05 considered significant.
Results Out of 650 participants with suspected COVID-19 (313 males and 145 females), 313 were confirmed to be positive for COVID-19 by quantitative RT–PCR (RT‒qPCR) using both samples. The ages ranged between 12 and 85 years, with a mean/standard deviation (SD) of 45.45 (16.62) years. All the cases with positive results using NPSs were also positive when SSs were used. Statistically, there was no significant difference between the two groups (p = 0.347).
Conclusion RT‒PCR assays conducted on SSs and NPSs performed similarly, indicating that SSs may be a safe, inexpensive diagnostic sampling method and an effective tool for population screening. We recommend more studies to support this finding.
Publikationsverlauf
Artikel online veröffentlicht:
13. Mai 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91 (01) 157-160
- 2 World Health Organization. Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases. Geneva:: World Health Organization; 2020: 1-7
- 3 Young BE, Ong SWX, Kalimuddin S. et al; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020; 323 (15) 1488-1494
- 4 Centers for Disease Control and Prevention. Updated Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19). Atlanta, GA: CDC; 2020
- 5 Caixeta DC, Oliveira SW, Cardoso-Sousa L. et al. One-year update on salivary diagnostic of COVID-19. Front Public Health 2021; 9: 589564
- 6 Kapoor P, Chowdhry A, Kharbanda OP, Bablani Popli D, Gautam K, Saini V. Exploring salivary diagnostics in COVID-19: a scoping review and research suggestions. BDJ Open 2021; 7 (01) 8
- 7 Wyllie AL, Fournier J, Casanovas-Massana A. et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl J Med 2020; 383 (13) 1283-1286
- 8 Marty FM, Chen K, Verrill KA. How to obtain a nasopharyngeal swab specimen. N Engl J Med 2020; 383 (03) e14
- 9 World Health Organization. Statement on Omicron sublineage BA.2. Accessed May 20, 2022 at: https://www.who.int/news/item/22-02-2022-statement-on-omicron-sublineage-ba.2
- 10 Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous waves. JAMA 2022; 327 (06) 583-584
- 11 Dawes C, Wong DTW. Role of saliva and salivary diagnostics in the advancement of oral health. J Dent Res 2019; 98 (02) 133-141
- 12 Miller M, Jansen M, Bisignano A. et al Validation of a self-administrable, saliva-based RT-qPCR test detecting SARS-CoV-2. . medRxiv 2020.06.05.20122721
- 13 Chu CY, Marais G, Opperman C. et al. Performance of saliva and mid-turbinate swabs for detection of the beta variant in South Africa. Lancet Infect Dis 2021; 21 (10) 1354
- 14 Marais G, Hsiao N-Y, Iranzadeh A. et al. Improved oral detection is a characteristic of omicron infection and has implications for clinical sampling and tissue tropism. J Clin Virol 2022; 152: 105170
- 15 To KKW, Tsang OT-Y, Yip CC-Y. et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020; 71 (15) 841-843
- 16 Azzi L, Carcano G, Gianfagna F. et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect 2020; 81 (01) e45-e50
- 17 Wyllie AL, Fournier J, Casanovas-Massana A. et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl J Med 2020; 383 (13) 1283-1286
- 18 Jamal AJ, Mozafarihashjin M, Coomes E. et al; Toronto Invasive Bacterial Diseases Network COVID-19 Investigators. Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2. Clin Infect Dis 2021; 72 (06) 1064-1066
- 19 Wang W-K, Chen SY, Liu IJ. et al; SARS Research Group of the National Taiwan University/National Taiwan University Hospital. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 2004; 10 (07) 1213-1219
- 20 Williams E, Bond K, Zhang B, Putland M, Williamson DA. Saliva as a non-invasive specimen for detection of SARS-CoV-2. J Clin Microbiol 2020; 58 (08) 1-2
- 21 Chen L, Zhao J, Peng J. et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell Prolif 2020; 53 (12) e12923
- 22 Azzi L, Carcano G, Dalla Gasperina D, Sessa F, Maurino V, Baj A. Two cases of COVID-19 with positive salivary and negative pharyngeal or respiratory swabs at hospital discharge: a rising concern. Oral Dis 2021; 27 (Suppl 3): 707-709
- 23 Pasomsub E, Watcharananan SP, Boonyawat K. et al. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin Microbiol Infect 2021; 27 (02) 285.e1-285.e4
- 24 Altawalah H, AlHuraish F, Alkandari WA, Ezzikouri S. Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: a cross-sectional study. J Clin Virol 2020; 132: 104652
- 25 Nasiri K, Dimitrova A. Comparing saliva and nasopharyngeal swab specimens in the detection of COVID-19: a systematic review and meta-analysis. J Dent Sci 2021; 16 (03) 799-805
- 26 Bastos ML, Perlman-Arrow S, Menzies D, Campbell JR. The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs: a systematic review and meta-analysis. Ann Intern Med 2021; 174 (04) 501-510
- 27 Migueres M, Mansuy J-M, Vasseur S. et al. Omicron wave SARS-CoV-2 diagnosis: evaluation of saliva, anterior nasal, and nasopharyngeal swab samples. Microbiol Spectr 2022; 10 (06) e0252122
- 28 Lai J, German J, Hong F. et al Comparison of saliva and midturbinate swabs for detection of SARS-CoV-2. Microbiol Spectr 2022; 10 (02) e0012822
- 29 Migueres M, Vellas C, Abravanel F. et al. Testing individual and pooled saliva samples for SARS-Cov-2 nucleic acid: a prospective study. Diagn Microbiol Infect Dis 2021; 101 (03) 115478
- 30 Khurshid Z, Asiri FYI, Al Wadaani H. Human saliva: Non-invasive fluid for detecting novel coronavirus (2019-nCoV). Int J Environ Res Public Health 2020; 17 (07) 1-4
- 31 Baum BJ, Yates III JR, Srivastava S, Wong DT, Melvin JE. Scientific frontiers: emerging technologies for salivary diagnostics. Adv Dent Res 2011; 23 (04) 360-368
- 32 Wong DT. Salivaomics. J Am Dent Assoc 2012; 143 (10) 19S-24S
- 33 Niedrig M, Patel P, El Wahed AA, Schädler R, Yactayo S. Find the right sample: a study on the versatility of saliva and urine samples for the diagnosis of emerging viruses. BMC Infect Dis 2018; 18 (01) 707
- 34 To KKW, Yip CCY, Lai CYW. et al. Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clin Microbiol Infect 2019; 25 (03) 372-378
- 35 Zhou P, Yang XL, Wang XG. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579 (7798) 270-273
- 36 Xu J, Li Y, Gan F, Du Y, Yao Y. Salivary glands: potential reservoirs for COVID-19 asymptomatic infection. J Dent Res 2020; 99 (08) 989
- 37 Yoon JG, Yoon J, Song JY. et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci 2020; 35 (20) e195
- 38 Uddin MKM, Shirin T, Hossain ME. et al. Diagnostic performance of self-collected saliva versus nasopharyngeal swab for the molecular detection of SARS-CoV-2 in the clinical setting. Microbiol Spectr 2021; 9 (03) e0046821
- 39 Gandhi RT, Lynch JB, Del Rio C. Mild or moderate covid-19. N Engl J Med 2020; 383 (18) 1757-1766
- 40 Kim YI, Kim SG, Kim SM. et al. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe 2020; 27 (05) 704-709.e2